AAIS
WST icon

ABN AMRO Investment Solutions’s West Pharmaceutical WST Stock Holding History

ABN AMRO Investment Solutions’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
3,913
+1,361
+53% +$416K 0.01% 466
2026
Q1 		$640K Buy
2,552
+214
+9% +$53.2K 0.01% 528
2025
Q4 		$643K Buy
+2,338
New +$640K 0.01% 477

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ABN AMRO Investment Solutions's WST Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its West Pharmaceutical (WST) stake by 53% in Q2 2026, buying an estimated $416K and bringing the position to 3,913 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #466.

ABN AMRO Investment Solutions first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • ABN AMRO Investment Solutions held 3,913 shares of West Pharmaceutical worth $1.4M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 1,361 West Pharmaceutical shares in Q2 2026, an estimated $416K.
  • West Pharmaceutical made up 0.01% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #466 holding.
  • ABN AMRO Investment Solutions first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.